Land: Singapúr
Tungumál: enska
Heimild: HSA (Health Sciences Authority)
ESTRADIOL
NOVARTIS (SINGAPORE) PTE LTD
G03CA03
0.75 mg/patch
PATCH
TRANSDERMAL
Prescription Only
LTS Lohmann Therapie-Systeme AG
1998-06-23
Drug Regulatory Affairs ESTRADERM ® MX (OESTRADIOL) TRANSDERMAL PATCH RELEASING 25, 50, 75, 100 micrograms/24 hours of oestradiol COUNTRY SPECIFIC PACKAGE LEAFLET IPL Creator: Sutirtha Roy CDS Author: Milena Vakrilova GLC approval: 16 February 2010 , amended 10 May 2011 Release date: 17 May 2011 Tracking Number: 2011-PSB/GLC-0406-e Document status: Final Number of pages: 13 Novartis Page 2 Country Specific Package Leaflet 17 May 2011 Estraderm MX ESTRADERM ® MX Hormone replacement therapy DESCRIPTION AND COMPOSITION PHARMACEUTICAL FORM Estraderm MX is a transdermal patch for application to an area of intact skin. The patch is a thin, flat multilaminate sheet, square with rounded corners, on an oversized protective liner. A drug/adhesive matrix which is laminated to a polyester backing film is in direct contact with the skin. The active substance from the adhesive matrix penetrates the skin and passes directly into the bloodstream. ACTIVE SUBSTANCE(S) CROSS SECTION DOSAGE STRENGTH The following four patches are available in Table 1: Table 1 ESTRADERM MX 25 ESTRADERM MX 50 ESTRADERM MX 75 ESTRADERM MX 100 Nominal rate of oestradiol release 25 micrograms/day 50 micrograms/day 75 micrograms/day 100 micrograms/day Content of oestradiol 0.75 mg 1.5 mg 2.25 mg 3.0 mg Drug-releasing area 11 cm 2 22 cm 2 33 cm 2 44 cm 2 Imprint (backing side) CG GRG CG GSG CG HKH CG GTG Release of the active substance is maintained for 4 days. Oestradiol hemihydrate. Transdermal patches with 0.75, 1.5, 2.25 and 3.0 mg of active substance are available. Novartis Page 3 Country Specific Package Leaflet 17 May 2011 Estraderm MX Certain dosage strengths may not be available in all countries. EXCIPIENTS Isopropyl palmita Lestu allt skjalið